Transpalpebral electrical stimulation for the treatment of retinitis pigmentosa: study protocol for a series of N-of-1 single-blind, randomized controlled trial
Authors:
Open Access
- 27 January 2024
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-8
Abstract
Background: Retinitis pigmentosa (RP) is an inherited disease characterized by a progressive loss of rod photoreceptors of the eye, leading to irreversible blindness. To date, to our knowledge, no clinical prospective studies have been undertaken that could document the effect of interventions that could reverse or reduce the progression of this disease. The application of microcurrent stimulation (ES) of the eye in the treatment of chronic eye diseases such as glaucoma and age-related macular degeneration has been used over several decades and has been reported to have beneficial effects to reduce the progression of these blinding diseases and has been supported by animal studies and smaller clinical studies, but to date, no large randomized clinical trials on the use of microcurrent therapy have been published. More recent clinical reports have also shown beneficial effects of ES on slowing the progression of RP but also lacks data from robust prospective clinical outcome studies. To our knowledge, this is the first prospective randomized study to evaluate the safety and clinical effectiveness of transpalpebral electrical stimulation (TpES) on the progression of RP. Methods: Randomized prospective study using N-of-1 trial 3 single-blind, crossover comparisons. The intervention period of each comparison is divided into treatment period and control period which are randomized arranged. Twelve participants will be strictly recruited in N-of-1 trial by the researcher in accordance with the inclusion and exclusion criteria. The main outcome of interest examined after each cycle of the 8-week intervention period is the assessment of the visual field (VF). Other variables of interest are best corrected visual acuity (BCVA), retinal function using electroretinogram (ERG), and visual function using NEI VFQ-25 questionnaire. Objective assessments of retinal changes will be undertaken using optical coherence tomography (OCT) and fundus autofluorescence (FAF). Discussion: The trial will evaluate the efficacy and safety of microcurrent stimulation on RP and provide high-quality evidence for clinical application through N-of-1 trial. Trial registration: Chinese Clinical Trial Registry; ChiCTR2300067357; https://www.chictr.org.cn/showproj.html?proj=174635. Registered on 5 January 2023Keywords
Funding Information
- National Natural Science Foundation of China (82274589, 81973912)
- Science and Technology Innovation Project in China Academy of Chinese Medical Sciences (CI2021A02602)
- China Center for Evidence-based Medicine of Traditional Chinese Medicine Special Project for Director of Business Research Office (2020YJSZX-2)
This publication has 22 references indexed in Scilit:
- Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: results from the TESOLAUK trialBMJ Open Ophthalmology, 2017
- Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosaGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- Randomized controlled trial of electro‐stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosaActa Ophthalmologica, 2017
- Neuroprotective effects of methyl 3,4 dihydroxybenzoate in a mouse model of retinitis pigmentosaExperimental Eye Research, 2017
- Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 YearInvestigative Ophthalmology & Visual Science, 2017
- Whole-eye electrical stimulation therapy preserves visual function and structure in P23H-1 ratsExperimental Eye Research, 2016
- Electrical stimulation ameliorates light-induced photoreceptor degeneration in vitro via suppressing the proinflammatory effect of microglia and enhancing the neurotrophic potential of Müller cellsExperimental Neurology, 2012
- OPTICAL COHERENCE TOMOGRAPHY IN RETINITIS PIGMENTOSARetina, 2012
- Transcutaneous Electrical Retinal Stimulation Therapy for Age-Related Macular DegenerationThe Open Ophthalmology Journal, 2006
- The Artificial Silicon Retina Microchip for the Treatment of VisionLoss From Retinitis PigmentosaArchives of Ophthalmology (1950), 2004